Pulmonary embolism (PE) is a life-threatening medical condition that can occur when a blood clot (or thrombus) travels from a vein in the body and lodges in the lungs. It is estimated that more than 600,000 people in the United States suffer from PE each year, and as many as 100,000 of them die. In an effort to prevent this potentially fatal condition, doctors have developed a type of medical device called an inferior vena cava (IVC) filter. This article will discuss the breakthrough of IVC filters in preventing life-threatening pulmonary embolism.
An IVC filter is a small medical device that is inserted into the inferior vena cava (IVC), the largest vein in the body. It is designed to capture and trap blood clots that travel through the veins and prevent them from reaching the lungs. The filter is usually inserted via a catheter into the IVC and is held in place by a small hook or anchor. It is typically left in place for up to three months, and then removed.
IVC filters are typically used in patients who have a high risk of developing a pulmonary embolism, such as those who have recently undergone surgery, have a history of deep vein thrombosis (DVT), or have a family history of PE. Patients who are unable to take anticoagulant medications (blood thinners) due to bleeding risks or other medical conditions may also be candidates for an IVC filter.
IVC filters offer several benefits for patients at risk for PE. First, they can reduce the risk of a potentially life-threatening PE by trapping and preventing the clot from reaching the lungs. Second, they can be used in patients who are unable to take anticoagulants due to bleeding risks or other medical conditions. Finally, they are minimally invasive and can be inserted and removed quickly and easily.
Although IVC filters are generally safe, there are some potential risks associated with their use. These include the risk of the filter migrating or becoming dislodged from its original position, the risk of the filter becoming clogged with clots, and the risk of infection. In addition, there is a risk of damage to the IVC or other nearby organs.
IVC filters are a breakthrough in the prevention of life-threatening pulmonary embolism. They are minimally invasive and can be inserted and removed quickly and easily. They can reduce the risk of a potentially fatal PE by trapping and preventing the clot from reaching the lungs. However, there are potential risks associated with their use, and patients should discuss these risks with their doctor before deciding to use an IVC filter.
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation